Menu
Recruiting NCT06528704

The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest.

No phase Interventional Cardiac Arrest

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ventilation feedback device.
Who it may be relevant to
Registry conditions: Cardiac Arrest. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

During out-of-hospital cardiopulmonary resuscitation, patient are first ventilated without ventilation feedback (but with a flowsensor connected), hereafter patients are ventilated with the use of ventilation feedback.

Detailed description

During cardiac arrest, patients are intubated, ventilation is performed using a manual resuscitator. Hereafeter, a flowsensor is connected. During the first cycle, patients are ventilated without any feedback (whilst the sensor is recording the delivered ventilation). During the second cycle, realtime delivered flow is shown on the screen, informing the user on the delivered ventilation volume and ventilation rate. Data is saved automatically after use.

Interventions

  • Device Ventilation feedback device
    Device showing delivered ventilation frequency and volume.

Primary outcome measures

  • Delivered ventilation frequency [Time frame: 2 minutes]
  • Delivered ventilation volume [Time frame: 2 minutes]

Eligibility criteria

Inclusion criteria

\-

Exclusion criteria

Traumatic cardiac arrest Inability to intubate patient

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Belgium · 2 centers
  • AZ Zeno — Knokke
  • Ghent University Hospital — Ghent

Identifiers

NCT: NCT06528704 · ONZ-2023-0613

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗